133 related articles for article (PubMed ID: 21250838)
1. Increased BCMA expression in lupus marks activated B cells, and BCMA receptor engagement enhances the response to TLR9 stimulation.
Kim J; Gross JA; Dillon SR; Min JK; Elkon KB
Autoimmunity; 2011 Mar; 44(2):69-81. PubMed ID: 21250838
[TBL] [Abstract][Full Text] [Related]
2. Stoichiometry of Heteromeric BAFF and APRIL Cytokines Dictates Their Receptor Binding and Signaling Properties.
Schuepbach-Mallepell S; Das D; Willen L; Vigolo M; Tardivel A; Lebon L; Kowalczyk-Quintas C; Nys J; Smulski C; Zheng TS; Maskos K; Lammens A; Jiang X; Hess H; Tan SL; Schneider P
J Biol Chem; 2015 Jun; 290(26):16330-42. PubMed ID: 25953898
[TBL] [Abstract][Full Text] [Related]
3. CD52 Is Elevated on B cells of SLE Patients and Regulates B Cell Function.
Bhamidipati K; Silberstein JL; Chaichian Y; Baker MC; Lanz TV; Zia A; Rasheed YS; Cochran JR; Robinson WH
Front Immunol; 2020; 11():626820. PubMed ID: 33658999
[TBL] [Abstract][Full Text] [Related]
4. Activation-induced necroptosis contributes to B-cell lymphopenia in active systemic lupus erythematosus.
Fan H; Liu F; Dong G; Ren D; Xu Y; Dou J; Wang T; Sun L; Hou Y
Cell Death Dis; 2014 Sep; 5(9):e1416. PubMed ID: 25210799
[TBL] [Abstract][Full Text] [Related]
5. CD19 Chimeric Antigen Receptor T Cell Treatment: Unraveling the Role of B Cells in Systemic Lupus Erythematosus.
Taubmann J; Müller F; Yalcin Mutlu M; Völkl S; Aigner M; Bozec A; Mackensen A; Grieshaber-Bouyer R; Schett G
Arthritis Rheumatol; 2024 Apr; 76(4):497-504. PubMed ID: 38114423
[TBL] [Abstract][Full Text] [Related]
6. BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial.
Wang W; He S; Zhang W; Zhang H; DeStefano VM; Wada M; Pinz K; Deener G; Shah D; Hagag N; Wang M; Hong M; Zeng R; Lan T; Ma Y; Li F; Liang Y; Guo Z; Zou C; Wang M; Ding L; Ma Y; Yuan Y
Ann Rheum Dis; 2024 May; ():. PubMed ID: 38777376
[TBL] [Abstract][Full Text] [Related]
7. B cell pathway dual inhibition for systemic lupus erythematosus: a prospective single-arm cohort study of telitacicept.
Ji L; Geng Y; Zhang X; Deng X; Song Z; Tan M; Tan Y; Qu C; Zhang Z
MedComm (2020); 2024 Apr; 5(4):e515. PubMed ID: 38525109
[TBL] [Abstract][Full Text] [Related]
8. Glucose oxidation-dependent survival of activated B cells provides a putative novel therapeutic target for lupus treatment.
Wilson JJ; Wei J; Daamen AR; Sears JD; Bechtel E; Mayberry CL; Stafford GA; Bechtold L; Grammer AC; Lipsky PE; Roopenian DC; Chang CH
iScience; 2023 Sep; 26(9):107487. PubMed ID: 37636066
[TBL] [Abstract][Full Text] [Related]
9. γ-Secretase directly sheds the survival receptor BCMA from plasma cells.
Laurent SA; Hoffmann FS; Kuhn PH; Cheng Q; Chu Y; Schmidt-Supprian M; Hauck SM; Schuh E; Krumbholz M; Rübsamen H; Wanngren J; Khademi M; Olsson T; Alexander T; Hiepe F; Pfister HW; Weber F; Jenne D; Wekerle H; Hohlfeld R; Lichtenthaler SF; Meinl E
Nat Commun; 2015 Jun; 6():7333. PubMed ID: 26065893
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF.
Abu-Rish EY; Amrani Y; Browning MJ
Rheumatology (Oxford); 2013 Jul; 52(7):1190-201. PubMed ID: 23436580
[TBL] [Abstract][Full Text] [Related]
11. Belimumab for the treatment of systemic lupus erythematosus.
Jordan N; D'Cruz DP
Expert Rev Clin Immunol; 2015 Feb; 11(2):195-204. PubMed ID: 25543845
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of B lymphocyte-induced maturation protein-1 reduces the production of autoantibody and alleviates symptoms of systemic lupus erythematosus.
Luo J; Niu X; Zhang M; Zhang K; Chen M; Deng S
Autoimmunity; 2015 Mar; 48(2):80-6. PubMed ID: 25347333
[TBL] [Abstract][Full Text] [Related]
13. The BAFF/APRIL system in SLE pathogenesis.
Vincent FB; Morand EF; Schneider P; Mackay F
Nat Rev Rheumatol; 2014 Jun; 10(6):365-73. PubMed ID: 24614588
[TBL] [Abstract][Full Text] [Related]
14. The BAFF/APRIL system: emerging functions beyond B cell biology and autoimmunity.
Vincent FB; Saulep-Easton D; Figgett WA; Fairfax KA; Mackay F
Cytokine Growth Factor Rev; 2013 Jun; 24(3):203-15. PubMed ID: 23684423
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the receptor BCMA as a biomarker in systemic lupus erythematosus patients.
Salazar-Camarena DC; Palafox-Sánchez CA; Cruz A; Marín-Rosales M; Muñoz-Valle JF
Sci Rep; 2020 Apr; 10(1):6236. PubMed ID: 32277232
[TBL] [Abstract][Full Text] [Related]
16. Abnormal expression of BAFF and its receptors in peripheral blood and skin lesions from systemic lupus erythematosus patients.
Chen Y; Yang M; Long D; Li Q; Zhao M; Wu H; Lu Q
Autoimmunity; 2020 Jun; 53(4):192-200. PubMed ID: 32157911
[TBL] [Abstract][Full Text] [Related]
17. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
18. Human Plasmacytoid Dendritic Cells Display and Shed B Cell Maturation Antigen upon TLR Engagement.
Schuh E; Musumeci A; Thaler FS; Laurent S; Ellwart JW; Hohlfeld R; Krug A; Meinl E
J Immunol; 2017 Apr; 198(8):3081-3088. PubMed ID: 28283566
[TBL] [Abstract][Full Text] [Related]
19. Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus.
Salazar-Camarena DC; Ortiz-Lazareno PC; Cruz A; Oregon-Romero E; Machado-Contreras JR; Muñoz-Valle JF; Orozco-López M; Marín-Rosales M; Palafox-Sánchez CA
Lupus; 2016 May; 25(6):582-92. PubMed ID: 26424128
[TBL] [Abstract][Full Text] [Related]
20. BAFF system expression in double negative 2, activated naïve and activated memory B cells in systemic lupus erythematosus.
Álvarez Gómez JA; Salazar-Camarena DC; Román-Fernández IV; Ortiz-Lazareno PC; Cruz A; Muñoz-Valle JF; Marín-Rosales M; Espinoza-García N; Sagrero-Fabela N; Palafox-Sánchez CA
Front Immunol; 2023; 14():1235937. PubMed ID: 37675114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
